Immunometabolic Pathways and Its Therapeutic Implication in Autoimmune Diseases

Area of Science:

• Immunology
• Metabolic pathways
• Autoimmune disease pathogenesis

Background:

• Autoimmune diseases (AIDs) involve aberrant immune responses affecting cell functions.
• Cell metabolism is crucial for immune cell energy and material supply.
• Emerging evidence links metabolic pathways to immune cell function and AID development.

Purpose of the Study:

• To review the metabolic characteristics of immune cells in AIDs.
• To summarize the roles of immunometabolism pathways in AIDs.
• To identify potential therapeutic targets within metabolic pathways for AIDs.

Main Methods:

• Literature review of immunometabolism in AIDs.
• Focus on glucose metabolism and the tricarboxylic acid (TCA) cycle.
• Analysis of intervention strategies targeting key metabolic regulators.

Main Results:

• Metabolic pathways critically influence immune cell function in AIDs.
• Specific pathways like glucose metabolism and TCA cycle are implicated.
• Targeting molecules such as mTOR, AMPK, and HIF1a shows therapeutic potential.

Conclusions:

• Immunometabolism plays a significant role in the pathogenesis of AIDs.
• Metabolic pathways offer promising targets for novel therapeutic interventions.
• Further research into immunometabolism could lead to effective treatments for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).